Medfinder
Back to blog

Updated: January 27, 2026

Ganciclovir Drug Interactions: What to Avoid and What to Tell Your Doctor

Author

Peter Daggett

Peter Daggett

Two medication bottles with drug interaction caution symbol

Ganciclovir interacts with several common medications, including some HIV drugs and antibiotics. Know what to avoid and what to tell your doctor before starting treatment.

Ganciclovir is a medication that interacts with several other drugs in ways that can be dangerous — some combinations can increase the risk of seizures, worsen bone marrow suppression, or significantly change how much ganciclovir or the other drug is in your bloodstream. Because ganciclovir is used in patients who are often on complex medication regimens — antiretrovirals, immunosuppressants, and antimicrobials — reviewing interactions is an essential step before starting treatment.

This guide covers the most important drug interactions with ganciclovir, organized by severity. Always tell your doctor and pharmacist about every medication you take — including over-the-counter drugs, vitamins, and supplements.

Interactions to Avoid — High Risk

These combinations should generally be avoided unless your doctor determines the benefits outweigh the risks:

Imipenem-cilastatin (Primaxin) — AVOID: Combining ganciclovir with this carbapenem antibiotic has been associated with generalized seizures in clinical reports. The exact mechanism is not fully understood. This combination should be avoided unless no alternatives exist and the benefit clearly outweighs the risk.

Ropeginterferon alfa-2b (Besremi) — AVOID: Both agents are myelosuppressive, meaning they suppress bone marrow function. Using them together increases the risk of dangerous blood count drops.

Major Interactions — Use With Caution, Close Monitoring Required

These interactions require your doctor and pharmacist to weigh the benefits and risks carefully. If used together, closer monitoring — usually more frequent blood tests — is essential:

Zidovudine (AZT, Retrovir): Both ganciclovir and zidovudine suppress bone marrow and can lower white blood cells, red blood cells, and platelets. Using them together increases the risk of severe neutropenia and anemia. Many patients cannot tolerate both drugs at full doses simultaneously. Your doctor may adjust doses or monitor your CBC more frequently.

Mycophenolate mofetil (CellCept) / Mycophenolate sodium (Myfortic): This immunosuppressant (used to prevent organ rejection) and ganciclovir each inhibit the replication of rapidly dividing cells. Together, they increase the risk of low blood counts. Both drugs also compete for renal tubular secretion, which can raise drug levels of each. Co-use is common in transplant patients and requires vigilant CBC monitoring.

Didanosine (ddI, Videx): When ganciclovir and didanosine are given together (particularly oral ganciclovir or valganciclovir), the blood levels of didanosine can increase substantially — in some studies by up to 50-111%. This raises the risk of didanosine side effects including pancreatitis and peripheral neuropathy. Monitoring is essential; dose adjustment of didanosine may be needed.

Abacavir (Ziagen) and other nucleoside reverse transcriptase inhibitors (NRTIs): Several NRTIs used in HIV treatment share bone marrow suppression risk with ganciclovir. Co-administration may increase hematologic toxicity — monitor CBC closely.

Moderate Interactions — Monitor Closely

Probenecid (Benemid): This gout medication competes with ganciclovir for renal tubular secretion. When taken together, probenecid can reduce how fast the kidneys clear ganciclovir from the body, increasing ganciclovir blood levels and the risk of side effects. Dose adjustment may be needed.

Tenofovir (TDF/TAF, Viread): Ganciclovir may increase tenofovir concentrations through competition for renal transport. Higher tenofovir levels increase the risk of kidney damage and bone side effects. Monitor kidney function and tenofovir-related toxicity.

Myelosuppressive chemotherapy and radiation: Drugs that suppress bone marrow (dapsone, pentamidine, flucytosine, vincristine, vinblastine, amphotericin B, trimethoprim/sulfamethoxazole, and other nucleoside analogues) all have the potential for additive toxicity with ganciclovir. These combinations should be used only when the benefits clearly outweigh the risks.

What to Tell Your Doctor Before Starting Ganciclovir

Before your first dose, give your doctor a complete medication list including:

All antiretroviral medications (especially zidovudine, abacavir, tenofovir, didanosine)

All immunosuppressants (especially mycophenolate mofetil, tacrolimus, cyclosporine)

All antibiotics — especially imipenem-cilastatin (Primaxin), trimethoprim/sulfamethoxazole (Bactrim), or dapsone

Any gout medication (especially probenecid)

Any cancer medications or chemotherapy agents

Herbal supplements — even commonly used ones like St. John's Wort or high-dose vitamins can interact with some antivirals

For a complete guide to managing ganciclovir side effects and monitoring, see our post on ganciclovir side effects.

If you're having trouble locating ganciclovir at a pharmacy near you, medfinder can help find which pharmacies currently have it in stock.

Frequently Asked Questions

Combining ganciclovir with zidovudine significantly increases the risk of bone marrow suppression — including severe neutropenia and anemia — because both drugs suppress bone marrow. Many patients cannot tolerate the combination at full doses. If both drugs are necessary, your doctor will likely monitor your blood counts very closely (weekly or more) and may reduce doses of one or both drugs. Always discuss this combination with your prescribing physician.

The combination of ganciclovir and imipenem-cilastatin (Primaxin) has been reported to cause generalized seizures. The exact mechanism is unknown, but the interaction appears to be pharmacodynamic (affecting brain activity) rather than pharmacokinetic. This combination should be avoided unless absolutely no alternatives exist, and patients who must receive both should be monitored closely for neurological symptoms.

Yes. Ganciclovir and mycophenolate mofetil (CellCept) both suppress the proliferation of rapidly dividing cells and compete for renal tubular secretion, which can increase blood levels of both drugs. This interaction is common in transplant patients who take mycophenolate as an immunosuppressant and require ganciclovir for CMV prophylaxis or treatment. Frequent CBC monitoring is required when both are used together.

Yes. Ganciclovir can increase tenofovir blood levels by competing for renal tubular transport. Higher tenofovir levels increase the risk of kidney toxicity and bone side effects. Patients on tenofovir-containing antiretroviral regimens who start ganciclovir should have kidney function monitored more closely. Inform your HIV specialist and infectious disease doctor about all medications you are taking.

Probenecid reduces the kidney's ability to clear ganciclovir from the blood by blocking renal tubular secretion. This increases ganciclovir blood levels and can intensify side effects, especially kidney toxicity and bone marrow suppression. If you take probenecid for gout and are starting ganciclovir, tell your doctor — they may need to reduce your ganciclovir dose or increase monitoring frequency.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Ganciclovir also looked for:

34,519 have already found their meds with Medfinder.

Start your search today.

34K+
5-star ratingTrusted by 34,519 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?